L ong noncoding RNAs (lncRNAs), defined as >200 nucleotides in length and often 3 0 polyadenylated, 1 are increasingly implicated in cardiovascular diseases. 2 Compared with mRNAs, lncRNAs are less abundant, mostly spliced but with fewer exons, and more species-and tissuespecific, 1, 3 emphasizing the importance of studies on humanand cell-specific lncRNAs in human physiology and diseases. As a critical component of the innate immune system, macrophages demonstrate remarkable plasticity and wideranging states of activation. Sustained and dysfunctional macrophage activation promotes inflammatory cardiometabolic diseases (CMDs) such as atherosclerosis and metabolic dysregulation. 4, 5 Macrophage activation to M1
(classic inflammatory activation by lipopolysaccharide and IFN-c [interferon c]) and M2 (alternatively activated by IL-4 [interleukin 4]) phenotypes are well characterized in vitro models for study of human and murine macrophage biology. 6, 7 Although the protein-coding transcriptome of human macrophages has been well characterized, 7-9 the lncRNA landscape in human macrophage biology remains elusive. Long intergenic noncoding RNAs (lincRNAs) lincRNACox2 10 and lincRNA-EPS 11 have been shown to be critical regulators of inflammation in murine macrophages, but both lack human orthologs, limiting translational relevance to human. A handful of studies have mapped human macrophage lncRNAs, most using microarray [12] [13] [14] and THP-1 monocytederived macrophages (THP-1Φ), 12 ,13 yet THP-1Φ is karyotypically abnormal and immature and thus may differ from primary human macrophages. 15 Recent FANTOM5 (functional annotation of the mammalian genome) cap analysis of gene expression data sets have profiled transcription start site (TSS) and enhancer elements of lncRNAs in human monocytederived macrophages, 16 ,17 yet deep RNA sequencing (RNAseq) of human macrophages has been lacking and is required to provide genomewide assembly of lncRNAs and to facilitate prioritization of promising lncRNAs for functional validation.
We have previously generated deep RNA-seq data sets of human peripheral blood mononuclear cell-derived macrophages (HMDMs) 18 with thorough characterization of their coding transcriptome 18 and alternative splicing events during M1 and M2 activation. 19 In this study, we focused on lincRNAs, a major subset of lncRNAs, using the same RNA-seq data sets. 18 LincRNAs do not overlap annotated proteincoding regions, facilitating experimental validation. 3 Because most genetic signals for complex traits are in intergenic regions, functional genetic variation in lincRNAs are likely to contribute to the intergenic genomewide association study (GWAS) signals for complex traits. 20 Through de novo transcriptome assembly, we (1) report a comprehensive lincRNA catalog (31% are newly annotated); (2) identify specific lincRNA expression patterns that correspond to distinct M1-and M2-activated phenotypes; (3) stratify macrophage lincRNAs based on synteny, conservation, tissue enrichment, and regulatory features defined by essential macrophage transcription factors (TFs) as well as histone H3 lysine 4 monomethylation (H3K4me1) and histone H3 lysine 4 trimethylation (H3K4me3) chromatin immunoprecipitation sequencing profiles 21, 22 ; (4) use GWAS data to identify macrophage lincRNAs related to human complex CMDs; (5) perform initial functional validation of MacORIS, a lincRNA that harbors single nucleotide polymorphisms (SNPs) associated with central obesity; and (6) characterize human induced pluripotent stem cell-derived macrophages (IPSDMs) as a model for functional assessment of human lincRNAs in macrophage biology. Our findings constitute a unique translational proof of principle and resource for the comprehensive interrogation of human macrophage lincRNAs in macrophage differentiation, inflammatory and metabolic functions, and relationship to human CMDs.
Clinical Perspectives
What Is New?
• This study provides a comprehensive bioinformatic inventory of 2766 human macrophage long intergenic noncoding RNAs (lincRNAs).
• Subsets of macrophage lincRNAs overlap genetic variants for complex cardiometabolic disease traits and modulate macrophage inflammatory functions.
• Human induced pluripotent stem cell-derived macrophages recapitulate the lincRNA transcriptome of monocyte-derived macrophages and provide a high-fidelity model with which to study human macrophage lincRNAs, particularly those not conserved in mouse, in macrophage biology and diseases.
What Are the Clinical Implications?
• Among the 2766 human macrophage lincRNAs, 861 lincRNAs are newly annotated. Most (85%) are not syntenic or are not annotated as expressed in mouse, and many (21.5%) demonstrate tissue-enriched expression patterns, underscoring the importance of human lincRNA discovery studies, using deep RNA sequencing and de novo assembly, in a species-and tissue-specific manner.
• MacORIS (macrophage-enriched obesity-associated lincRNA serving as a repressor of IFN-c [interferon c] signaling) harbors variants associated with central obesity and functions as a brake on macrophage IFN-c signaling, a very plausible mechanism for modulation of central obesity and related metabolic disorders.
• Targeting macrophage lincRNAs may have therapeutic potential in macrophage-related disorders in humans including metabolic disorders, atherosclerosis, and coronary artery diseases.
and in Data S1. Briefly, human peripheral blood mononuclear cells were differentiated to macrophages using 100 ng/mL macrophage colony-stimulating factor, and activation was induced by 18-to 20-hour incubation with 100 ng/mL lipopolysaccharide and 20 ng/mL IFN-c for M1-like activation or 20 ng/mL IL-4 for M2-like activation. 18 Strand-specific, poly(A)+ libraries underwent deep sequencing at 100-bp paired-end reads to obtain in macrophages %130 million filtered reads per sample with >95% mapping rate 18 and in monocytes %280 million filtered reads per sample with >93% mapping rate. 23 RNA-seq reads were aligned with the hg19 reference genome, and transcript abundance was measured in FPKM (fragments per kilobase of transcript per million fragments mapped) using Cufflinks 2.1.1. 24 De novo assembly was performed using Cufflinks 2.1.1. 24 Differential expression, defined as false discovery rate-adjusted (FDR-adjusted) P<0.01 and a fold change >2, was tested with Cuffdiff. RNAseq data are available under the accession number GSE55536. 18 (Table S1 shows participant demographics, and Figure S1 shows correlation between biological replicates). The bioinformatics pipeline for the annotation of the human macrophage lincRNA catalog, including the long intergenic transcript filters, coding potential filters and reliable expression filters, is outlined in Figure 1 and described in detail in Data S1.
Synteny and Conservation Analysis
Synteny is defined as conserved gene order along the chromosomes of different species. We examined the synteny of macrophage lincRNAs in mouse using HomoloGene release 68, then further subdivided syntenic lincRNAs as annotated or not annotated in mouse, using GENCODE M4 annotation. To evaluate sequence conservation for syntenic lincRNAs, the human lincRNA sequence was queried against the mouse genome with an E-value cutoff of 1910 À10 using BLASTN.
Sequence hits in the mouse within the syntenic region were then searched in human samples with the same E-value cutoff. Sequences that passed the reciprocal steps were considered conserved. 
Interrogation of Genomic Regions From GWAS
We first explored the overlap of macrophage-enriched lincRNAs with trait-associated SNPs that reached a significance level of P<1910 À5 using data from the comprehensive NHGRI (National Human Genome Research Institute) GWAS Catalog. 27 To further interrogate SNPs within macrophage lincRNAs for specific association with the 13 cardiometabolic traits (Table S2), 63 586 genotyped and imputed (HAPMAP  28 ) SNPs were mapped to macrophage lincRNAs (AE1 kb) and interrogated using either the minimum P value for the corresponding SNPs within each lincRNA (Bonferroni-adjusted threshold of P<0.05) 29 or a class-based method, GenCAT (Genetic Class Association Testing), 30 to test the overall impact of all SNPs within the region. Significantly associated lincRNAs were further prioritized to include only those that contained the strongest SNP-level P value in the region (AE500 kb of the lincRNA) or if it was in low-linkage disequilibrium (r 2 <0.3) with a stronger single SNP in the region, suggesting an independent signal at the lincRNA locus.
Validation, Characterization, and Initial Functional Studies of Candidate lincRNAs
Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was used to validate lincRNA expression, and primers are listed in Table S3 . Knockdown of a top GWASassociated lincRNA, MacORIS, was performed in THP-1Φ by transfection of single-stranded antisense oligonucleotides (Exiqon) and small interfering RNA (Dharmacon) using Lipofectamine RNAiMAX Transfection Reagent (Thermo Fisher Scientific). Western blotting was used to determine expression and phosphorylation of JAK2 (Janus kinase 2; Try1008) and STAT1 (signal transducer and activator of transcription 1; Tyr701). Flow cytometry was used to determine the expression of IFNGR1 (IFN-c receptor 1).
Statistical Analyses
Specific analyses of RNA-seq and genomic data are described within each section. For analysis of gene ontology pathways in RNA-seq data, significant enrichment was declared at FDRadjusted P<0.05 using the Benjamini and Hochberg method. 29 Nonsequencing data were analyzed with GraphPad Prism 6 (GraphPad Software). Differences between 2 groups were assessed by Student t tests (2-tailed). One-way ANOVA followed by the Dunnett test was used to correct for multiple comparisons. Results were declared significant if P<0.05.
Results

Whole-Transcriptome Profiling Identifies Previously Unannotated Human Macrophage lincRNAs
We interrogated a stringent set of known multiexon human lincRNAs (>200 bp, no overlap with a protein-coding gene within AE1 kb of lincRNAs) collated from (1) the "Cabili" Human BodyMap "stringent" data set (4273 lincRNAs) 3 and (2) the GENCODE V19 data set (7114 lincRNAs; Figure 1 ). 31 By combining the 2 sets, a catalog of 8045 known multiexon lincRNAs was generated. Next, we performed de novo transcriptome assembly by Cufflinks v2.1.1 and excluded previously annotated multiexon lincRNAs, as described in Figure 1 . Global discovery of human macrophage lincRNAs. Polyadenylated RNA sequencing data generated from M0 HMDM and M1-or M2-activated HMDM were analyzed by the bioinformatics pipeline outlined for the annotation of known lincRNAs (the Cabili set and GENCODE V19) and newly annotated lincRNAs (from de novo assembly). FPKM indicates fragments per kilobase of transcript per million fragments mapped; HMDM, human peripheral blood mononuclear cell-derived macrophages; IFN-c, interferon c; IL-4, interleukin-4; lincRNA, long intergenic noncoding RNA; LPS, lipopolysaccharide; PBMC, peripheral blood mononuclear cells.
Data S1. We filtered single-exon lincRNAs because of greater probability of transcriptional noise. 32 We applied a coding potential filter on newly annotated lincRNAs using iSeeRNA 33 and HMMER-3 on Pfam 34 ( Figure 1 ). To identify lincRNAs that were robustly and reliably expressed in human macrophages, we included only lincRNAs expressed at >1% FPKM based on FPKMs for all lincRNAs and mRNAs in at least 50% of subjects in all HMDM samples. Through this conservative, multilayered analysis, we identified 2766 distinct multiexon lincRNAs that are reliably expressed in human macrophages, of which 861 were previously unannotated ( Figure 1 ). Coding potential for all 2766 lincRNAs was further validated by PhyloCSF, 35 as described in Data S1, and the lincRNAs with scores higher than the threshold cutoff were listed in Table S4 . Among the 2766 lincRNAs, 1282 lincRNAs were found in all 6 M0, M1, or M2 HMDMs, and 562 lincRNAs were expressed in all 18 unique macrophage samples (Table S5) . More than 50% (1407) of lincRNAs were found across all M0-, M1-, and M2-HMDM activation states, whereas a smaller portion of lincRNAs were highly specific to M0, M1, or M2 HMDMs ( Figure S2A ). These latter "activation state"-specific lincRNAs were more likely to be previously unannotated lincRNAs ( Figure S2B and S2C), underscoring the importance of interrogating lincRNAs within cell-specific and functional contexts.
Expression and Conservation of Macrophage lincRNAs
As in other cell types, 3 compared with protein-coding genes, macrophage lincRNAs were generally expressed with less abundance, were shorter, and had fewer exons than mRNAs ( Figure 2A and Figure S3 ). Expression levels of newly annotated macrophage lincRNAs were lower than those of known lincRNAs (Kolmogorov-Smirnov test, P<2.2910
À16
; Figure 2A ). Compared with known lincRNAs, newly annotated lincRNAs showed lower percentages of synteny and annotation in mouse. The lincRNAs that were syntenic and annotated in mouse showed higher expression than other lincRNAs. C, The lincRNA sequence conservation between human and mouse in syntenic regions was examined using BLASTN (see Methods). The lincRNAs demonstrated poor sequence conservation in the syntenic regions, and newly annotated lincRNAs were less conserved than known ones. FPKM indicates fragments per kilobase of transcript per million fragments mapped; lincRNA, long intergenic noncoding RNA.
( Figure 2B ). Among the 1678 syntenic lincRNAs, only 24% (395) demonstrated significant sequence conservation (Figure 2C ) between human and mouse. 37 Compared with previously known lincRNAs, a lower proportion of newly annotated macrophage lincRNAs was conserved (28% versus 15%, respectively; P=3.49910 À9 ), suggesting a higher level of species specificity ( Figure 2C ). Although lincRNAs that were syntenic and annotated as expressed in mouse showed higher expression in human macrophages than other lincRNAs ( Figure 2B ), sequence conservation per se was not associated with expression levels in human macrophage ( Figure 2C ).
Tissue Enrichment and TF Profiles of Macrophage lincRNAs
Enrichment of lincRNAs in macrophages, relative to other tissues, may suggest their specific roles in macrophage biology. Consequently, we determined the tissue enrichment of macrophage lincRNAs by calculating their expression in macrophages relative to the sum of expression across 16 tissues in data from the Human BodyMap RNA-seq. 3 Applying a fractional expression of >0.2 to define "enriched" lincRNAs, 3 595 lincRNAs within the 2766 macrophage lincRNAs (21.5%) demonstrated enriched expression in HMDMs (Table S5) . Relative to protein-coding genes, macrophage lincRNAs were proportionally more macrophage enriched (eg, 15.3% versus 9.8% in M0 HMDM; Figure 3A ). Certain lincRNAs were specifically enriched only in M1 or M2 HMDM ( Figure 3B , Table S5 ). Expression levels of macrophage-enriched lincRNAs were higher than those of nonenriched lincRNAs ( Figure 3C ). PU.1 and C/EBPb are essential TF regulators of macrophage differentiation. 22 Leveraging public data sets (GSE31621), 22 we discovered that TF occupancy was significantly higher around (AE2 kb) lincRNA TSS and gene bodies for macrophage-enriched lincRNAs than for non-macrophage-enriched lincRNAs; indeed, the majority of the enriched lincRNAs demonstrated PU.1 or C/ EBPb binding ( Figure 3D ). In comparing M0 HMDM to our human monocyte data (RNA-seq of 6 age-and race-matched subjects 23 ; Table S1 ), numerous lincRNAs were differentially expressed (DE; fold change >2 and FDR <0.01) during monocyte transition to HMDM ( Figure S4A and S4B and C/EBPb binding sites, and most (72 of 114) were also macrophage enriched ( Figure S4C and S4D) . This highlights the potential roles of a subset of highly macrophage-specific lincRNAs in macrophage maturation and function.
Regulatory Features of Macrophage lincRNAs
Regulatory features at lincRNA loci increase the likelihood of biological and functional roles. Many macrophage lincRNAs overlap macrophage enhancer marks. Using public human macrophage chromatin immunoprecipitation sequencing data sets, 21 the majority of protein-coding genes (15 201 genes) displayed punctate binding of the H3K4me3 promoter mark around the TSS (AE1.5 kb). In contrast, lincRNA TSS intervals showed relatively weaker signals, and only a small subset displayed high H3K4me3 density. In contrast, binding of H3K4me1, an enhancer mark, at lincRNAs was greater than at protein-coding genes ( Figure 4A ). Transcription from putative enhancer regions characterized by high levels of H3K4me1 relative to the H3K4me3 is a major feature of enhancer RNAs, 38 and lncRNAs that act as enhancer RNAs have been shown to modulate monocyte immune response. 39 For macrophage lincRNAs, we used H3K4me1/H3K4me3 ratios of >1.2 and <0.8 to define enhancer and promoter states, 39 respectively. In contrast to the predominance of promoter features at mRNAs ( Figure 4A and Table S5 ), the majority of macrophage lincRNAs and H3K4me1 (enhancer mark) across the AE1.5-kb region around the transcription start site and the H3K4me1/H3K4me3 ratios of proteincoding genes and lincRNAs show distinct enhancer-driven transcript signatures in macrophage lincRNAs vs protein-coding genes. Profiles were sorted based on mean H3K4me3 intensity. B, We used H3K4me1/H3K4me3 ratios of >1.2 and <0.8 to define enhancer and promoter states, 39 respectively. The correlation of fold change in expression during M1 activation (M0 vs M1) of "elincRNAs" and their closest protein-coding genes was significantly stronger than that for "plincRNAs." elincRNA indicates enhancer-associated lincRNA; H3K4me1, histone H3 lysine 4 monomethylation; H3K4me3, histone H3 lysine 4 trimethylation; lincRNA, long intergenic noncoding RNA; plincRNA, promoter-associated lincRNA.
(60.9%, 994 of a total of 1632 M0-HMDM lincRNAs with H3K4me1 and H3K4me3 signals) exhibited an H3K4me1/ H3K4me3 ratio of >1.2, suggestive of "elincRNAs" with potential enhancer functions based on bioinformatics prediction (Table S5) . Furthermore, elincRNAs were more macrophage enriched but had lower expression levels compared with promoter-associated lincRNAs, or "plincRNAs." Consistent with previous findings in mouse erythroblasts, 40 the polyadenylated macrophage elincRNAs in our catalog were more likely to have unidirectional transcription ( Figure S5A through S5C), unlike most nonpolyadenylated bidirectional enhancer RNAs. 38 We hypothesized that elincRNAs that overlap enhancer signatures (H3K4me1/H3K4me3 >1.2), would have greater coregulation with nearby protein-coding genes during M1 activation than lincRNAs with classical promoter signatures (H3K4me1/H3K4me3 <0.8). The correlation of fold change in expression during M1 activation (M0 versus M1) of elincRNAs and their closest protein coding genes was significantly stronger than that for plincRNAs (Z test, P=0.0039; Figure 4B ). Gene ontology analysis of the 194 protein-coding genes nearest the M1-induced elincRNAs revealed enrichment for mRNAs involved in immune response and response to bacteria as well as transcriptional regulation ( Figure S5D and Table S7 ). Ingenuity pathway analysis also suggested M1 activation related signaling and biological functions (Figure S5E and S5F and  Tables S8 and S9 ). Indeed, a number of elincRNAs were paired with neighboring protein-coding genes known to have roles in the macrophage inflammatory response, including Acyl-CoA Synthetase Long-Chain Family Member 1 (proximal to RP11-701P16.5), Interleukin 6 (proximal to AC002480.2), C-C Motif Chemokine Ligand 8 (proximal to CUFF.135177), Interferon Induced Transmembrane Protein 3 (proximal to RP11-326C3.12), and Heparan Sulfate-Glucosamine 3-Sulfotransferase 3B1 (proximal to AC022816.2), or novel GWAS genes, such as Transmembrane Protein 171 (proximal to linc-ZNF366-6) associated with serum urate and gout, 41 and Chromosome 6
Open Reading Frame 223 (proximal to CUFF.59743 and CUFF.59265), associated with circulating levels of vascular endothelial growth factor 42 (see Table S10 for complete list).
The genomic structure and the potential cis-regulatory effects of these elincRNAs on their coding gene partners require further functional investigation. Thus, macrophage enrichment and TF binding patterns facilitate prioritization of macrophage lincRNAs that are more likely to be functional, whereas enhancer features suggest mechanistic avenues to pursue in translation.
M1 Activation Induced Widespread Changes in lincRNA Expression
Macrophage activation induces widespread change in the protein-coding gene transcriptome, 18 but lincRNA modulation during macrophage activation is largely unexplored. During M1 activation, 96 lincRNAs were DE (fold change >2, FDRadjusted P<0.01), with 73 up-and 23 downregulated, of which 22 were newly annotated ( Figure 5A and Table S11 ). In contrast to M1 activation, only 5 lincRNAs were DE (all upregulated) during M2 activation ( Figure 5B ; Table S12 ), consistent with the modest difference in mRNAs between IL-4-derived M2 HMDM and their macrophage colony-stimulating factor-differentiated M0 HMDM. 18 Relative to all macrophage lincRNAs, those that were DE during macrophage activation were more likely to be syntenic and annotated as expressed in mouse (15% versus 27%; P=0.0013), suggesting that synteny may be a feature of some physiologically relevant macrophage lincRNAs. In contrast, primary sequence conservation with mouse was not associated with DE lincRNAs in macrophage activation (%25% in both groups). We focused further on lincRNAs that were upregulated in M1 or M2 activation and also macrophage-enriched, because mRNAs with such features have been shown to contain many important protein-coding genes with functional roles in macrophage biology. . These data highlight a promising subset of human macrophage lincRNAs for follow-up. Based on abundance, extent of induction, tissue enrichment, and TF binding, we selected 10 lincRNAs (8 most upregulated in M1 activation and 2 most upregulated in M2 activation) for qRT-PCR validation and translational exploration. Using a set of independent macrophage samples (n=8 subjects), qRT-PCR analysis replicated the pattern of activation-induced lincRNA expression identified at RNA-seq for all lincRNAs ( Figure 5C for M1-induced, and Figure 5D for M2-induced). Of these, MIR155HG is nonsyntenic; RP11-10J5.1, RP11-701P16.5, CTB-41I6.2, and RP5-836N10.1 are syntenic but not annotated as expressed in mouse; and linc-HEATR6-2, linc-SLC39A10-10, MIR146A, RP4-794H19.4 and RP11-184M15.1 are syntenic and annotated in mouse ( Figure 5C and 5D). None of these lincRNAs showed significant sequence conservation in mouse. Of these 10 lincRNAs, 6 had enhancerlike histone signatures (see Table S13 for a summary). As an example, we showed the qRT-PCR validation of CUFF.15750, one of the most abundantly expressed de novo annotated lincRNAs, which was suppressed during both M1 and M2 activation and has PU.1 and C/EBPb binding and enhancerlike features. Public cap analysis of gene expression peak data were consistent with the apparent TSS for CUFF.15750 revealed by our RNA-seq ( Figure S6 ).
GWASs Reveal Potential Disease-Associated Macrophage lincRNAs
The majority of genetic variants associated with complex diseases are found within noncoding regions of the genome, where the functional consequences of the variation are largely unknown. Consequently, we explored the overlap of macrophage lincRNAs with disease-associated genetic variations in public data sets. First, to probe broadly whether macrophage lincRNAs may underlie disease associations, we explored genomic loci for the 595 macrophage-enriched lincRNAs that contained SNP data within the comprehensive GWAS catalog 27 with trait associations of P<1910 À5 . We identified 66 macrophage-enriched lincRNAs containing traitassociated SNPs and highlighted those traits for which macrophages have been implicated, including metabolic (eg, obesity-related traits, visceral fat, and waist-hip ratio) and immune disorders (eg, Crohn disease, multiple sclerosis, and celiac disease; boldface in Table S14) . Second, because of the central role of macrophage activation in multiple CMDs, we interrogated SNPs within all macrophage-expressed lincRNAs for their specific association with 13 cardiometabolic traits (Table S2) . Of the 2766 macrophage-expressed lincRNAs, 2340 lincRNAs contained SNPs that were tested in at least 1 of the 13 GWAS data sets. Using our published pipelines, 20, 30 lincRNAs containing significant trait-associated SNPs were filtered stringently to include only those that contained the strongest and independent (r 2 <0.3; based on 1000Genomes CEU data 44 ) SNP-level P value in the region (AE500 kb of the lincRNA; see Methods for details). By further filtering for the most prominently expressed lincRNAs (FPKM >0.1, corresponding to top %35% expressed macrophage lincRNAs), we identified 3 independent trait-associated SNPs-for waist-to-hip ratio adjusted for body mass index, plasma triglycerides, and plasma lowdensity lipoprotein-cholesterol-that fall within AE1 kb of highly expressed macrophage lincRNAs (Table) .
A top trait association is at a lincRNA annotated as RP11-472N13.3, which we named MacORIS. MacORIS overlaps rs7081678, an SNP associated with central obesity (waist-hip ratio adjusted for body mass index); maps to the chromosome 10p11.22 locus ( Figure 6A through 6C) ; and is a macrophageenriched lincRNA that is syntenic but not annotated in mouse. MacORIS is expressed predominantly in M0 HMDM (fractional expression value: 0.44), is barely detectable in human primary adipocytes, and is found at low levels in human adipose cells ( Figure 6D ) and T cells ( Figure 6E) . A genome browser view of MacORIS shows abundant PU.1 and C/EBPb binding (Figure 6F ) but no annotation in Genome Reference Consortium Mouse Build 38 (GRC38/mm10) and no expression in published high-quality RNA-seq of murine bone marrowderived macrophages ( Figure 6G and Table S15 ). MacORIS does not contain a conserved open reading frame, and in vitro transcription and translation of MacORIS did not produce any detectable peptides ( Figure S7A ). The qRT-PCR of cell fractions revealed that MacORIS is predominantly located in cytoplasm ( Figure 6H ), suggesting potential posttranscriptional regulatory roles. M1, but not M2, stimulation suppressed MacORIS expression ( Figure 6I and 6J). To examine the functional impact of MacORIS on M1 activation, we used GapmeR antisense oligonucleotide to knock down MacORIS in THP-1Φ and found enhanced expression of IFN-c-induced negative regulators SOCS1 and SOCS3 but no effect on lipopolysaccharide-induced inflammatory genes such as TNF, TNFAIP3, and IL1B ( Figure 6K ). Cytoplasmic localization suggests that MacORIS modulates cytoplasmic activation, rather than nuclear expression, of IFN-c-signaling molecules. 
LincRNAs Are Expressed and Modulated Similarly in Human IPSDMs and Primary HMDMs
It is important to consider human-relevant strategies and to develop tools for functional interrogation of human lincRNAs not expressed in mouse. IPSDMs are a renewable source of subject-specific macrophages and provide a powerful functional genomic tool to address human macrophage biology. We reported previously that IPSDMs had comparable phenotypes, protein-coding transcriptomes, and functional characteristics as HMDMs and can be used for functional genomic modeling of protein-coding genes. 18 In this article, we extended our IPSDM model for our current lincRNA perspective by examining DE lincRNAs between induced pluripotent Table S16 ) had higher expression ( Figure 7D ) and had enriched PU.1 and C/EBPb TF binding ( Figure 7E ).
The vast majority (>90%) of the M0 HMDM lincRNAs were also present in M0 IPSDMs, and their expression was moderately correlated (r=0.51; Figure 7F ). Remarkably, for %95% of lincRNAs, there was a similar pattern of activationrelated change in expression in both HMDMs and IPSDMs with strong correlations (eg, r=0.81 between IPSDMs and HMDMs for M1-activation-induced fold change of lincRNAs; Figure 7G and 7H; Tables S11 and S12). Indeed, only very few lincRNAs were DE between HMDMs and IPSDMs ( Figure 7F and Table S17 ). For the very small number of lincRNAs that were expressed at lower levels in M0 IPSDMs than in M0 HMDMs (eg, linc-SLC39A10-10), on activation, their expression in M1 or M2 IPSDMs was comparable to that in M1 or M2 HMDMs (Table S18) . As a relevant example, a genome browser view of MacORIS shows consistent expression patterns for HMDMs and IPSDMs at rest and during M1 activation ( Figure 6F ). Overall, IPSDM lincRNA expression and activation profiles resemble those of HMDMs, supporting the utility of the IPSDM system for functional modeling of lincRNAs in human macrophage genomics. 
Discussion
Macrophages modulate many human pathophysiologies and have emerged as potential therapeutic targets in complex diseases. 5 Although a recent microarray-based study has characterized lncRNAs in M1-and M2-activated HMDMs, 14 there is a lack of RNA-seq-based, unbiased cataloging of the human macrophage lncRNA transcriptome. By exploiting de novo transcriptome reconstruction of deep RNA-seq data, we provide the most comprehensive inventory and genomic Consistent with the pattern for mRNAs, 7-9,18 M1 activation induces profound changes in lincRNA expression with induction of dozens of lincRNAs. Correlation of activationdependent change in enhancer lincRNA expression with that of the nearest protein-coding genes maps to regulation of immune system processes and suggests an integrative regulatory role for some lincRNAs during macrophage activation. Indeed, through our prioritization strategy, we identified that lincRNAs reported previously to modulate myeloid cell functions (eg, linc-HEATR6-2, also named lnc-DC) were recently reported to regulate dendritic cell maturation and function. 47 (Table S19 ). M1 and M2 activation in vitro, however, provides a relatively narrow window into the diversity of macrophage activation states observed in vivo; future transcriptional profiling of resident macrophages across diverse tissues and settings will provide deeper insight into the in vivo complexity of the human macrophage noncoding transcriptome. Recent GWASs have revealed novel functional lncRNAs in disease, for example, ANRIL at the 9p21.3 locus for coronary heart disease 50 and Lnc13 at 2q12.1 for celiac disease. 51 These human genetic studies suggest that lincRNAs may play important modulatory roles in human diseases. Indeed, we identified hundreds of macrophage lincRNAs that reside within intergenic loci previously identified by GWASs for complex traits. We performed a deeper interrogation of lincRNAs in 13 CMD data sets and identified several promising candidates including MacORIS, which we found to act as a repressor of IFN-c signaling by regulating phosphorylation of JAK2 and STAT1. Notably, IFN-c deficiency protects mice from high fat diet-induced white adipose tissue inflammatory cell accumulation and glucose tolerance. 46 Thus, MacORIS modulation of IFN-c signaling in macrophages is a plausible mechanism underlying the 10p11.22 locus for central obesity. However, the causal variant at MacORIS and the precise genetic and cellular mechanisms of action of MacORIS require further investigation. MacORIS is one of many human lincRNAs not present in mice. This lack of conservation combined with historical limitations of human macrophage models presents a specific challenge to functional studies of lincRNAs in human macrophage biology. RNA interference and antisense oligonucleotide-based knockdown approaches in primary monocytes and macrophages are challenging, given low transfection rates and heterogeneity between experiments. THP-1 monocyte and macrophage lines, although useful, as we demonstrate for MacORIS, are karyotypically abnormal and phenotypically immature, 15 thus also not an ideal model for human functional genomics. We developed a high-fidelity model for human macrophage functional genomics studies. 18 Our results in this study reveal comparable lincRNA transcriptome profiles and dynamic regulation during activation in isogenic IPSDMs and HMDMs. Coupled to CRISPR/Cas9 gene editing that precisely introduces targeted mutations and deletions, 52 IPSDM provides a powerful tool to decipher the genomic and molecular regulation of human macrophage lincRNAs in human physiology and disease. Recently, the FANTOM CAT (CAGE-associated transcriptome)-a human transcriptome meta-assembly based on cap analysis of gene expression data across 1829 samples from major human primary cell types and tissues as well as transcript models from GENCODE V19, the Cabili set, miTranscriptome, and ENCODE-has defined 27 919 lncRNAs, of which 13 105 were lincRNAs. 53 We found 901 of 2766 of our macrophage lincRNAs overlapped FANTOM CAT lincRNAs within AE250 bp of the TSS (Table S20) . Because the FANTOM5 CAT included human macrophages from only 3 donors, additional macrophage lincRNAs will be added to such public resources as sample size and sequencing depth increase, as in our study. Nonetheless, the precise 5 0 -end transcript mapping in FANTOM5 CAT lincRNAs is complementary to but less comprehensive than our deep RNA-seq-based human macrophage lincRNA catalog.
In the current work, we focused on lincRNAs for both technical and translational reasons. LncRNAs that either overlap (ie, antisense) or share a TSS interval with proteincoding genes confound simple interpretation of regulatory features in the region and complicate genetic manipulation in functional studies. There are also analytic challenges in dissecting the contribution of GWAS disease-associated SNPs residing in lncRNAs that overlap protein-coding genes. Consequently, lncRNAs excluded from our analysis, including lincRNAs proximal to the coding genes, antisense lncRNAs shown to regulate THP-1Φ function, 54 and single-exon transcripts are likely to provide additional layers of information about the macrophage noncoding transcriptome. Our study has many strengths but limitations too. Our lincRNA catalog derived from poly(A) capture RNA-seq fails to include nonpolyadenylated lncRNAs and short noncoding RNAs. It has been reported that 84.2% and 74.2% of the annotated expressed lncRNAs are poly(A)+ in H9 and Hela cells, respectively; 13.1% and 23.3% are bimorphic, found in both the poly(A)+ and poly(A)À populations, respectively; and 2.7% and 2.5% are poly(A)À, suggesting the majority of the lncRNAs are poly(A)+ or bimorphic, respectively. 55 The classification, however, has not been performed in human macrophage. Coding potential was assessed by computational prediction using iSeeRNA 33 and Pfam 34 with validation by PhyloCSF 35 but not with experimental approaches. A fully comprehensive macrophage lncRNA catalog derived from RNA-seq of ribosomal RNA-depleted samples combined with both bioinformatic and experimental approaches for coding potential assessment will further refine the human macrophage lncRNA catalog for future study. In the meantime, a large number of prioritized lincRNAs in our study remains to be functionally validated to gain deeper mechanistic insights into lincRNA modulation of human macrophage biology and their role in human diseases. Our work underscores the importance of lincRNA discovery studies, using deep RNA-seq and de novo assembly, in a species-and tissue-specific manner. It also provides a resource to parse the polyadenylated lincRNA circuitry of macrophage activation and to identify specific lincRNAs for functional studies in macrophage activation and macrophagerelated human diseases, as we have explored for MacORIS. Our IPSDM model provides a unique framework with which to pursue the human macrophage-specific functions of novel lincRNAs in macrophage biology and related diseases and for gene-editing strategies to advance mechanism-based clinical and therapeutic translation of human genomic discoveries. 
Sources of Funding
Differentiation of PBMC and monocytes-derived macrophage (HMDM)
Isolated PBMCs or monocytes were cultured in macrophage culture media containing 20% fetal bovine serum in RPMI 1640 media supplemented with 100 ng/mL M-CSF (PeproTech, Cat# 300-25), for 7 days on BD Primaria TM tissue culture plate to induce macrophage differentiation as we described.
1 Subject-specific iPSCs derivation, culture and maintenance Generation and characterization of subject-specific induced pluripotent stem cells (iPSCs) were performed by the iPSC Core Facility at Penn's Institute of Regenerative Medicine. iPSCs were derived from PBMCs using Sendai viral vectors as described.
1
Differentiations of human iPSCs-derived macrophages (IPSDM) Detailed protocols were described in our recent publication. 1 Briefly, to induce differentiation, embryoid bodies were generated by culturing small aggregates of feeder-depleted iPSCs in COSTAR ultra-low attachment surface multiwell plate in StemPro-34 media supplemented with different cytokine cocktails. From day-8, macrophage culture media was used to enrich for myeloid precursors. At day-15, single cells were transferred to BD Primaria TM tissue culture plate for expansion and maturation, completed at day-22.
HMDM and IPSDM activation Macrophage activation was induced by 18-20h incubation with 20 ng/mL IFN- and 100 ng/mL LPS for M1-like activation, or 20 ng/mL IL-4 for M2-like activation.
1 RNA-seq library preparation and sequencing As we described, 1, 2 RNA samples were extracted using All Prep DNA/RNA/miRNA Universal Kit (Qiagen, Valencia, CA). With a minimum of 300 ng input RNA, libraries were prepared using the ruSeq RNA Library Prep Kit v2 (RS-122-2101, Illumina, San Diego, CA) according to the manufacturer's protocol with the following modification: 1) the fragmentation time was decreased from 8 to 6 min to ensure libraries were > 100bp long and 2) PCR amplification was limited to 12 cycles for library enrichment to avoid bias from PCR "jackpot" mutations. Library length and concentration were evaluated with the Agilent 2100 Bioanalyzer and PCR quantification (KAPA) and pooled at 2 nM for massively parallel sequencing (2 x 100 bp) performed on an Illumina's HiSeq 2000.
1, 2 On average, in macrophage samples we obtained ~130 million filtered reads per sample with >95% mapping rate and in monocyte samples ~280 million filtered reads per sample with >93% mapping rate.
Coding potential assessment was initially performed with iSeeRNA 13 and HMMER-3 on Pfam 14 on newly annotated macrophage lincRNAs. To further validate the effectiveness of coding potential assessment and perform additional coding potential filtering on the annotated lincRNA datasets, we applied PhyloCSF, 15 another widely used coding potential assessment tool to both annotated and newly annotated macrophage lincRNAs. For each lincRNA transcript, PhyloCSF was run on multiple sequence alignment of 29 mammalian genomes to identify ORFs in all three frames. A lincRNA was classified as coding if any of its transcripts had a score ≥100. The score cutoff of 100 was chosen to optimize the balance of false negative vs. false positive rates. 10 Conservation and synteny analysis Many functional lincRNAs are known to have synteny (genomic regions flanked by homologous protein-coding genes) 16 despite low sequence similarity across species. [17] [18] [19] We examined the synteny of 2,766 macrophage lincRNAs in mouse using HomoloGene release 68 (http://www.ncbi.nlm.nih.gov/homologene) as previously described. 20 The neighboring genes of lincRNAs in human were identified, and the homologous genes were searched in HomoloGene. If homologous genes in the mouse were found for the two nearest neighboring genes in the human, we considered the lincRNA syntenic. Syntenic lincRNAs were further sub-divided as annotated or not annotated in mouse, using GENCODE M4 annotation (http://www.gencodegenes.org/mouse_releases/4.html), to assess whether there were annotated mouse lincRNAs in syntenic regions. For syntenic lincRNAs, we evaluated their sequence conservation using BLASTN. 21 The human lincRNA sequence was queried against the mouse genome with an E-value cutoff of 1 x 10 -10 . Any hits in the mouse within the syntenic region were then searched in human with the same E-value cutoff. Sequences that passed the reciprocal steps were considered conserved.
Tissue enrichment of HMDM mRNAs and lincRNAs
We estimated lincRNA and mRNA gene expression in M0-, M1-and M2-HMDM, and 16 tissues using Human BodyMap RNA-seq datasets. 10 For each lincRNA and mRNA, we calculated its fractional expression level in each tissue by dividing the FPKM value by total FPKM value across HMDMs and 16 tissues. e.g. The fractional expression level of a linRNA in M0-HMDM is calculated as "FPKM(M-HMDM) / [FPKM(M0-HMDM)+FPKM(tissue 1)+…+FPKM(tissue16)]". K-means clustering was applied to mRNA and lincRNA fractional expression values using Euclidean distance as described.
22
Histone modification profile analysis Histone H3 lysine 4 monomethylation (H3K4me1), 23, 24 histone H3 lysine 4 trimethylation (H3K4me3), 23 and histone H3 lysine 27 acetylation (H3K27ac) 24 ChIP-seq datasets for human HMDM were downloaded from GSE31621 24 or GSE58310. 23 We selected 2,009 lincRNAs that were expressed in at least 50% M0 samples as well as 15, 201 mRNAs expressed in at least 50% M0 samples. 1,632 lincRNAs and 14,606 mRNAs had H3K4me1 and H3K4me3 signals. Histone modification was quantified within ±1.5 kb of each mRNA or lincRNA TSS using computeMatrix from deepTools v1.5.11. 25 Histone modification was then visualized using heatmapper option from deepTools. The H3K4me1/H3K4me3 ratio was calculated by dividing the mean H3K4me1 signal by mean H3K4me3 signal within the ±1.5kb region.
Analysis of unidirectional and bidirectional transcription
Bidirectional transcription is defined as transcription that occurs on both the forward and reverse strands of DNA simultaneously. Analysis was performed as previously described. 26 We first summarized the number of RNA-seq reads at the region of ±1 kb of lincRNA TSS. A minimum number of 3 reads was used to define transcription. For the region with transcription: 1) If there is no coverage at the region between TSS and 1 kb upstream of the lincRNA TSS, or there is coverage but the strand is the same as the lincRNA strand, we classify a lincRNA as unidirectionally transcribed. If there is coverage and on the strand opposite to the lincRNA strand, we classify the lincRNA as a bidirectionally transcribed.
Transcription factor binding analysis We downloaded PU.1 and C/EBPβ peaks identified in human macrophages from GSE31621. 24 Peaks from two replicates for each were merged. We then mapped the merged peaks to ±2kb of each TSS and gene body and counted the number of lincRNAs with PU.1 and C/EBPβ binding in all the M0-HMDM lincRNAs.
Interrogation of Genomic Regions from Genome-Wide Association Study (GWAS)
First, to probe broadly whether macrophage lincRNAs may underlie disease associations, we explored the overlap of M0-, M1-and M2-HMDM enriched macrophage lincRNAs with known disease-associated variants using data from the comprehensive NHGRI GWAS Catalog. 27 SNP coordinates were lifted from hg38 to hg19. Trait-associated SNPs that reached significance level of P < 1 x10 -5 were extracted if they overlapped macrophage lincRNAs.
Second, because of the important role of macrophage activation in cardiometabolic disease, we interrogated SNPs within macrophage-expressed lincRNAs for their specific association with 13 cardiometabolic traits using large public GWAS meta-analysis summary datasets (Table S2) . Briefly, 63,586 genotyped and imputed (HAPMAP 28 ) SNPs were mapped to macrophage lincRNAs (±1kb) and interrogated using two analytic strategies for each trait of interest. First, the minimum P value (minP) for the corresponding SNPs within each lincRNA was reported and considered significant if it met a Bonferroni-adjusted threshold of P <0.05, and the Bonferronicorrected P values were adjusted for the number of SNPs within all macrophage lincRNAs. 29 Second, a class-based method Genetic Class Association Testing (GenCAT) 30 was also applied to test the overall impact of all the SNPs within the interrogated lincRNA region. Briefly, GenCAT uses the SNP-level meta-analysis test statistics across all SNPs within a single class (e.g., a lincRNA), as well as the size of the class and its unique correlation structure, to determine if it is statistically meaningful. A class was considered significant if it had a GenCAT P value that met a Bonferroni-corrected threshold (adjusted for the number of lincRNAs present in the given consortia) P <0.05. These analyses were conducted separately for each trait within consortia datasets. Significant lincRNAs (by either minP or class-based analysis) were further prioritized to only include those that contained the strongest SNP level P value in the region (±500kb of the lincRNA) or if it was in low linkage disequilibrium (r 2 <0.3; based on 1000Genomes CEU data 31 ) with a stronger single SNP in the region, suggesting a significant independent signal at the lincRNA locus.
Quantitative real-time RT-PCR Total RNA was isolated using the miRNeasy kit and underwent on-column DNase treatment (Qiagen). Reverse transcription was performed from equal amounts of DNA-free RNA (300 ng) per sample using the High Capacity RNA to cDNA Master Mix kit (Applied Biosystems). Diluted cDNA was then used as input for quantitative RT-PCR analysis performed in a total volume of 10 l on the QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems) using SYBR green PCR mix (Bio-Rad). Primers were designed using NCBI and obtained from IDT and are listed in Table S3 . The specificity of each amplified product was monitored through the use of melting curves at the end of each amplification reaction. Unless otherwise indicated, each transcript's cycle threshold (Ct) value was normalized to the ACTB Ct value for each sample, and a transcript's relative expression was determined through the 2 -(ΔΔCt) method.
Nuclear and cytoplasmic RNA fractionation As previously described, 20 for localization of lincRNAs prioritized for further study, HMDM cell pellet underwent subcellular fractionation using the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Fisher Scientific, Cat# 78833) with the addition of RNase inhibitor (Thermo Fisher Scientific, Cat# 10777019) to the lysis buffers. Total RNA was then isolated from each subcellular fraction using the miRNeasy kit (Qiagen). Quantitative real-time RT-PCR was performed for the lincRNAs in each fraction, with normalization of each fraction to the mean Ct of U6 using U6 snRNA Taqman microRNA assay (Thermo Fisher Scientific, Cat# 4427975) and ACTB combined. To ensure each subcellular fraction had only limited cross-contamination, relative U6 and ACTB levels were measured separately to confirm their abundance in the nuclear and cytoplasmic compartments, respectively.
THP-1 cell culture
THP-1 human acute monocytic leukemia cell line was obtained from ATCC (ATCC® TIB-202™) and grown in suspension in in RPMI-1640 media supplemented with 10% FBS, 1 mM Sodium Pyruvate, 10 mM HEPES, and 50 M 2-Mercaptoethanol. THP-1 macrophages were differentiated from THP-1 monocytic cell lines in THP-1 culture media supplemented with 100 nM Phorbol 12-myristate 13-acetate (PMA) for 3 days. 
Knockdown of MacORIS
Flow cytometry analysis
THP-1 were dissociated using Cellstripper (Corning, Cat# 25-056-Cl), washed in staining buffer (BD, Cat# 554656), and blocked with 20 l Fc-receptor antibodies for 10 min on ice, and then stained with PE anti-human CD119 (IFN- R  chain) antibody (Biolegend, Cat# 308703, 1:100 dilution from 400 g/mL) at 4 g/mL for 20 minutes on ice. The negative controls were stained using PE Mouse IgG1, κ Isotype Ctrl at 4 g/mL (Biolegend, Cat# 400111, 1:50 dilution from a stock of 200 g/mL). Samples were analyzed using BD LSRII flow cytometer (BD Biosciences, San Jose, CA). Cells were plotted according to forward scatter and side scatter profiles and gated to exclude cell doublets and debris. Data were analyzed by using FlowJo software (Tree Star, Ashland, OR). Table S1 . Subject demographics of RNA-seq studies.
The numbers "1" and "2" in the table represent the number of biological replicates. 
M2-HMDM
Pearson's r=0.9887 Figure S2 . The "activation state"-specific lincRNAs were more likely to be previously unannotated lincRNAs.
Among the 2,766 lincRNAs, over 50% (1,407) of the lincRNAs were expressed across M0-, M1-, and M2-HMDM activation states while a small percentage of lincRNAs were highly specific to either M0-, M1-or M2-HMDMs A small percentage of lincRNAs were highly specific to either M0-, M1-or M2-HMDMs (A). (B) and (C) Compared to the 861 newly annotated lincRNAs out of the 2,766 macrophage lincRNAs, there were 196 newly annotated lincRNAs out of 426 M1-specific lincRNAs (P =2.58x10 -12 ) and 85 newly annotated lincRNAs out of 201 M2-specific lincRNAs (P =6.33x10 -4 ) by Fisher's exact test, underscoring the importance of interrogating lincRNAs within a cell-specific and functional context. Kolmogorov-Smirnov test, P < 2.2x10 -16 LincRNAs Coding genes (A) Using our RNA-seq dataset of CD14 + monocytes (age/race matched, n=6 subjects), 37 we identified differentially expressed lincRNAs during monocyte to M0-HMDM differentiation; compared to monocytes, 114 lincRNAs were up-regulated in M0-HMDM and 186 lincRNAs were down-regulated in M0-HMDM. Table S7 ). (E) Top 5 canonical pathways in the nearest coding genes to the up-regulated enhancer lincRNAs in M1-activation (see complete list in Table S8 ). (F) Ingenuity Pathway Analysis using the nearest coding genes to the up-regulated enhancer-associated lincRNAs in M1-activation. The diagram reflects the regulatory networks, which show direct (solid line) and indirect (dash line) interactions between all the genes (red, upregulated; green, down-regulated).
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